Linda S. Birnbaum, Ph.D., DAPT, ATS, is director of the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH), and National Toxicology Program (NTP). As NIEHS and NTP director, Dr. Birnbaum oversees a budget that funds multidisciplinary biomedical research programs, prevention, and intervention efforts that encompass training, education, technology transfer, and community outreach. The NIEHS supports more than 1,000 research grants. A board-certified toxicologist, Dr. Birnbaum has served as a federal scientist for nearly 32 years. Prior to her appointment as the NIEHS and NTP director in 2009, she spent 19 years at the U.S. Environmental Protection Agency (EPA) where she directed the largest division focusing on environmental health research. Dr. Birnbaum started her federal career with 10 years at the NIEHS, first as a senior staff fellow at the National Toxicology Program, then as a principal investigator and research microbiologist, and finally as a group leader for the Institute’s Chemical Disposition Group. Dr. Birnbaum has received numerous awards and recognitions. She was elected to the Collegium Ramazzini, received an honorary doctor of science from the University of Rochester, and a Distinguished Alumna Award from the University of Illinois. In October 2010, she was elected to the Institute of Medicine of the National Academies. Her awards include the Women in Toxicology Elsevier Mentoring Award, the Society of Toxicology Public Communications Award, EPA’s Health Science Achievement Award and Diversity Leadership Award, and 12 Science and Technology Achievement Awards. She is the author of more than 700 peer-reviewed publications, book chapters, abstracts, and reports. Dr. Birnbaum received her M.S. and Ph.D. in microbiology from the University of Illinois at Urbana-Champaign.
David J. Carey, Ph.D., is associate chief research officer, director, and senior scientist of the Sigfried and Janet Weis Center for Research at the Geisinger Health System. Dr. Carey has extensive research experience in the areas of cellular and molecular biology, and is now extensively engaged in genomics research on vascular disease and other areas. He has served as a key player in the development of translational genomics research at Geisinger since 2004. Dr. Carey received his Ph.D. from St. Louis University.
David Cole, M.S., is regional discipline leader for production technology for Shell’s Upstream Americas Business Unit. In this role, he oversees the activities of Shell’s 200 production engineers in the Americas. Mr. Cole joined Shell in 1981 as a production engineer. He spent the next 10 years being responsible for conventional and unconventional fields in Shell’s Onshore and Offshore businesses. Mr. Cole then moved to Shell’s Bellaire Research Center where he was a member of a team positioning Shell for its entrance into the Deepwater. In 1993, Mr. Cole transferred back to a production engineering technical specialist before